share_log

GeneDx to Participate in Upcoming Investor Conference

GeneDx to Participate in Upcoming Investor Conference

GeneDx将参加即将举行的投资者会议
GeneDx Holdings ·  11/21 21:00

STAMFORD, Conn.--(BUSINESS WIRE)--Nov. 22, 2024--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET.

康涅狄格州斯坦福德--(美国商业资讯)--2024年11月22日--通过基因组洞察改善健康状况的领导者GenedX(纳斯达克股票代码:WGS)今天宣布,公司管理层将参加12月3日至5日在纽约州纽约市举行的派珀·桑德勒第36届年度医疗保健会议。管理层将于美国东部时间2024年12月3日星期二下午 1:00 参加炉边谈话。

Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

直播和存档的网络直播将在GenedX投资者关系网站ir.genedx.com/news-events/events/events的 “活动” 栏目上播出。

About GeneDx

关于 GenedX

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

在GenedX(纳斯达克股票代码:WGS),我们相信每个人都应该得到个性化、有针对性的医疗服务,而这一切都始于基因诊断。在世界上最大的罕见病数据集之一的推动下,我们行业领先的外显子组和基因组测试将复杂的基因组数据转化为临床答案,从而解锁个性化健康计划,加速药物发现,提高卫生系统效率。欲了解更多信息,请访问 genedx.com 并通过 LinkedIn、X、Facebook 和 Instagram 联系我们。

View source version on businesswire.com:

在 businesswire.com 上查看源版本:

Investor Relations:
investors@GeneDx.com

投资者关系:
investors@GeneDx.com

Media:
press@GeneDx.com

媒体:
press@GeneDx.com

Source: GeneDx

资料来源:GenedX

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发